Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1/2a Exploratory Clinical Trial: Induced Suppression of Platelets Activity in Aneurysmal SAH Management (iSPASM)

NCT03691727 is registered in ClinicalTrials.gov with David Hasan as lead sponsor.

NCT NCT03691727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03691727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1/2a Exploratory Clinical Trial: Induced Suppression of Platelets Activity in Aneurysmal SAH Management (iSPASM)
Lead sponsor
David Hasan
Phase
Phase 1/2
Overall status
Completed
Start date
January 24, 2019
Completion date
July 1, 2021
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

subarachnoid hemorrhage, aneurysmal